Key Takeaways

  1. After the early posttrauma period, PTSD rates changed little: prevalence fell from 25.9% at baseline to 13.3% at 6 months, then remained between 9.6% and 13.0% through 24 months, suggesting that persistent symptoms by 6 months may mark a more chronic course.
  2. Among youth without PTSD at both baseline and 1 month, subsequent PTSD was uncommon at 2.6–4.2%, supporting a lower-intensity follow-up strategy when repeated early assessments are both negative.
  3. Comorbid anxiety/depressive disorders and current psychiatric care identified higher-risk youth even after accounting for initial PTSD, with OR =2.15, 95% CI, 1.55–2.99 and OR =1.72, 95% CI, 1.29–2.28, respectively; disruptive behavior/substance use was not a significant signal in this model.
  4. Intentional trauma remained a stronger longitudinal predictor than unintentional or witnessed intentional trauma, with OR =2.53, 95% CI, 1.77–3.61; trauma occurring 12 or more months before baseline also carried higher odds of later PTSD (OR =1.91, 95% CI, 1.05–3.46), so remote trauma does not imply low current risk.
  5. Perceived social support was protective only for ages 8–17 years (OR =0.58, 95% CI, 0.39–0.88) and not for ages 18–20 years (OR =0.80, 95% CI, 0.52–1.23), which may justify more active family, school, and peer support assessment in children and adolescents.
  6. Older age and female sex were associated with later PTSD independent of initial status, with OR =1.78, 95% CI, 1.31–2.41 for ages 13–17 years, OR =2.71, 95% CI, 1.65–4.46 for ages 18–20 years, and OR =1.78, 95% CI, 1.31–2.41 for female sex, while race and ethnicity were not significant.
Read full article
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.